Small molecule grp94 inhibitors block dengue and Zika virus replication
Two major flaviviruses, dengue virus (DENV) and Zika virus (ZIKV), cause severe health and economic burdens worldwide. Recently, genome-wide screenings have uncovered the importance of regulators of the Hrd1 ubiquitin ligase-mediated endoplasmic reticulum (ER)-associated degradation (ERAD) pathway f...
| Principais autores: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Publicado em: |
Elsevier Masson
2019
|
| Assuntos: |
| _version_ | 1825722093273088000 |
|---|---|
| author | Rothan, Hussin A. Zhong, Yongwang Sanborn, Mark A. Teoh, Teow Chong Ruan, Jingjing Yusof, Rohana Hang, Jun Henderson, Mark J. Fang, Shengyun |
| author_facet | Rothan, Hussin A. Zhong, Yongwang Sanborn, Mark A. Teoh, Teow Chong Ruan, Jingjing Yusof, Rohana Hang, Jun Henderson, Mark J. Fang, Shengyun |
| author_sort | Rothan, Hussin A. |
| collection | UM |
| description | Two major flaviviruses, dengue virus (DENV) and Zika virus (ZIKV), cause severe health and economic burdens worldwide. Recently, genome-wide screenings have uncovered the importance of regulators of the Hrd1 ubiquitin ligase-mediated endoplasmic reticulum (ER)-associated degradation (ERAD) pathway for flavivirus replication in host cells. Here we report the identification of the compound Bardoxolone methyl (CDDO-me) as a potent inhibitor of the Hrd1 ubiquitin ligase-mediated ERAD, which possesses a broad-spectrum activity against both DENV and ZIKV. Cellular thermal shift assay (CETSA) suggested that CDDO-me binds to grp94, a key component of the Hrd1 pathway, at a low nanomolar concentration, whereas interaction was not detected with its paralog Hsp90. CDDO-me and the grp94 inhibitor PU-WS13 substantially suppressed DENV2 replication and the cytopathic effects caused by DENV and ZIKV infection. The antiviral activities of both compounds were demonstrated for all four DENV serotypes and four ZIKV strains in multiple human cell lines. This study defines grp94 as a crucial host factor for flavivirus replication and identified CDDO-me as a potent small molecule inhibitor of flavivirus infection. Inhibition of grp94 may contribute to the antiviral activity of CDDO-me. Further investigation of grp94 inhibitors may lead to a new class of broad-spectrum anti-flaviviral medications. © 2019 Elsevier B.V. |
| first_indexed | 2024-03-06T06:00:23Z |
| format | Article |
| id | um.eprints-23623 |
| institution | Universiti Malaya |
| last_indexed | 2024-03-06T06:00:23Z |
| publishDate | 2019 |
| publisher | Elsevier Masson |
| record_format | dspace |
| spelling | um.eprints-236232020-01-29T04:15:13Z http://eprints.um.edu.my/23623/ Small molecule grp94 inhibitors block dengue and Zika virus replication Rothan, Hussin A. Zhong, Yongwang Sanborn, Mark A. Teoh, Teow Chong Ruan, Jingjing Yusof, Rohana Hang, Jun Henderson, Mark J. Fang, Shengyun QR Microbiology R Medicine Two major flaviviruses, dengue virus (DENV) and Zika virus (ZIKV), cause severe health and economic burdens worldwide. Recently, genome-wide screenings have uncovered the importance of regulators of the Hrd1 ubiquitin ligase-mediated endoplasmic reticulum (ER)-associated degradation (ERAD) pathway for flavivirus replication in host cells. Here we report the identification of the compound Bardoxolone methyl (CDDO-me) as a potent inhibitor of the Hrd1 ubiquitin ligase-mediated ERAD, which possesses a broad-spectrum activity against both DENV and ZIKV. Cellular thermal shift assay (CETSA) suggested that CDDO-me binds to grp94, a key component of the Hrd1 pathway, at a low nanomolar concentration, whereas interaction was not detected with its paralog Hsp90. CDDO-me and the grp94 inhibitor PU-WS13 substantially suppressed DENV2 replication and the cytopathic effects caused by DENV and ZIKV infection. The antiviral activities of both compounds were demonstrated for all four DENV serotypes and four ZIKV strains in multiple human cell lines. This study defines grp94 as a crucial host factor for flavivirus replication and identified CDDO-me as a potent small molecule inhibitor of flavivirus infection. Inhibition of grp94 may contribute to the antiviral activity of CDDO-me. Further investigation of grp94 inhibitors may lead to a new class of broad-spectrum anti-flaviviral medications. © 2019 Elsevier B.V. Elsevier Masson 2019 Article PeerReviewed Rothan, Hussin A. and Zhong, Yongwang and Sanborn, Mark A. and Teoh, Teow Chong and Ruan, Jingjing and Yusof, Rohana and Hang, Jun and Henderson, Mark J. and Fang, Shengyun (2019) Small molecule grp94 inhibitors block dengue and Zika virus replication. Antiviral Research, 171. p. 104590. ISSN 0166-3542, DOI https://doi.org/10.1016/j.antiviral.2019.104590 <https://doi.org/10.1016/j.antiviral.2019.104590>. https://doi.org/10.1016/j.antiviral.2019.104590 doi:10.1016/j.antiviral.2019.104590 |
| spellingShingle | QR Microbiology R Medicine Rothan, Hussin A. Zhong, Yongwang Sanborn, Mark A. Teoh, Teow Chong Ruan, Jingjing Yusof, Rohana Hang, Jun Henderson, Mark J. Fang, Shengyun Small molecule grp94 inhibitors block dengue and Zika virus replication |
| title | Small molecule grp94 inhibitors block dengue and Zika virus replication |
| title_full | Small molecule grp94 inhibitors block dengue and Zika virus replication |
| title_fullStr | Small molecule grp94 inhibitors block dengue and Zika virus replication |
| title_full_unstemmed | Small molecule grp94 inhibitors block dengue and Zika virus replication |
| title_short | Small molecule grp94 inhibitors block dengue and Zika virus replication |
| title_sort | small molecule grp94 inhibitors block dengue and zika virus replication |
| topic | QR Microbiology R Medicine |
| work_keys_str_mv | AT rothanhussina smallmoleculegrp94inhibitorsblockdengueandzikavirusreplication AT zhongyongwang smallmoleculegrp94inhibitorsblockdengueandzikavirusreplication AT sanbornmarka smallmoleculegrp94inhibitorsblockdengueandzikavirusreplication AT teohteowchong smallmoleculegrp94inhibitorsblockdengueandzikavirusreplication AT ruanjingjing smallmoleculegrp94inhibitorsblockdengueandzikavirusreplication AT yusofrohana smallmoleculegrp94inhibitorsblockdengueandzikavirusreplication AT hangjun smallmoleculegrp94inhibitorsblockdengueandzikavirusreplication AT hendersonmarkj smallmoleculegrp94inhibitorsblockdengueandzikavirusreplication AT fangshengyun smallmoleculegrp94inhibitorsblockdengueandzikavirusreplication |